Pneumeric, Inc. has formed a distribution agreement with JP Pharma to provide Capnospot® Tension Pneumothorax Decompression Indicator in Brazil, enhancing emergency care. The device offers visual confirmation of needle placement for faster intervention. Both companies express optimism about the partnership and its impact on saving lives in Brazil.
Pneumeric, Inc. has announced a distribution partnership with JP Pharma for the Capnospot® Tension Pneumothorax Decompression Indicator, allowing access to vital medical technology for police, military, and emergency responders in Brazil. This innovative device offers visual confirmation of needle placement through a simple color change, facilitating prompt life-saving treatments.
JP Pharma, a prominent tactical medical supplier in Latin America, represents esteemed international medical device manufacturers. The addition of the Capnospot® device aligns with both companies’ business strategies, enhancing the demand for advanced medical solutions in Brazil.
Bruno Tavora, Chief Operating Officer of JP Pharma, expressed enthusiasm for the collaboration, stating that it will contribute significantly to pre-hospital care and save lives in Brazil. Similarly, Deon Miller, Chief Commercial Officer of Pneumeric, expressed confidence in the mutual benefits of the partnership for both firms, anticipating a successful launch of Capnospot® in Brazil.
The Capnospot® device is designed to improve accuracy in tension pneumothorax decompression procedures, offering real-time visual confirmation and thus enhancing patient care during critical situations.
Pneumeric, Inc. was established in 2021 with a mission to improve tension pneumothorax treatment outcomes. The firm received FDA clearance in 2023 and holds two patents for the Capnospot® device. Further details about Capnospot and the company can be found at their website.
Founded in 2008, JP Pharma focuses on importing and distributing high-quality medical products. Their mission centers around equipping Brazil with advanced medical technology through strategic partnerships. More information is available on their website.
The strategic partnership between Pneumeric, Inc. and JP Pharma signifies a significant advancement in pre-hospital medical care in Brazil. The introduction of the Capnospot® device has the potential to enhance treatment accuracy for tension pneumothorax, ultimately saving lives. Both companies convey strong commitment to innovation and healthcare excellence, indicating a promising future for their collaboration.
Original Source: www.prweb.com
